Rasimcan Meral

8PUBLICATIONS
37CO-AUTHORS
Medical biochemistry - lipidsRadiation therapyPredictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Condensed matter imaging
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 29, 2026
Unraveling the natural history of lipodystrophy syndromes: insights from the prospective LD-Lync study.

|Mar 10, 2025
Metabolic Improvements With Tirzepatide in Lipodystrophy: A Novel Option?

Rasimcan Meral, Merve Celik Guler, Diarratou Kaba

|Jan 13, 2025
Tirzepatide for Lipodystrophy.

Rasimcan Meral, Merve Celik Guler, Diarratou Kaba

|Oct 14, 2024
RAI therapy in low-risk papillary thyroid cancer: recurrence reduction and long-term outcomes in the Turkish population.

Seckin Bilgic, Rasimcan Meral, M Sait Sağer

|Oct 28, 2022
COSMC expression as a predictor of remission in IgA nephropathy.

Sebahat Usta Akgul, Cigdem Kekik Cinar, Yasar Caliskan

|Oct 22, 2021
Endogenous Leptin Concentrations Poorly Predict Metreleptin Response in Patients With Partial Lipodystrophy.

Rasimcan Meral, Noemi Malandrino, Mary Walter

Pageof 2

Frequent Collaborators

6 joint publications

Elif Arioglu Oral

3 joint publications

Rebecca J Brown

2 joint publications

Baris Akinci

2 joint publications

Maria Cristina Foss-Freitas